Quent Capital »

Karyopharm Therapeutics shares owned by Quent Capital

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Quent Capital from 13F filings

Historical chart of Quent Capital investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Quent Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Quent Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5k 231 6.54
2025-03-31 $864 231 3.74

More positions owned by Quent Capital

Vanguard Russell 1000 Growth Etf Etf (VONG)
Spdr Nuveen Ice Short Term Municipal Bond Etf Etf (SHM)
Ishares Msci Eafe Growth Etf Etf (EFG)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares 1-3 Year Treasury Bond Etf Etf (SHY)
Dimensional Us Large Cap Value Etf Etf (DFLV)
Apple Stock (AAPL)
Ishares Gold Trust Etf (IAU)
Ishares Msci Emerging Markets Etf Etf (EEM)
Spdr Bloomberg Short Term International Treasury Bond Etf Etf (BWZ)
Nvidia Corporation Stock (NVDA)
Dimensional International Value Etf Etf (DFIV)
Avantis U.s. Small Cap Value Etf Etf (AVUV)
Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Spdr Dow Jones Global Real Estate Etf Etf (RWO)

View all positions for Quent Capital

Top funds holding Karyopharm Therapeutics

T. Rowe Price Investment Management
Adage Capital Partners GP
Vanguard Group
Susquehanna International
BlackRock
Affinity Asset Advisors
Catalio Capital Management
Avidity Partners Management
Marshall Wace
CAM Group Holding A/S
Geode Capital Management
Citadel Advisors
Group One Trading
Renaissance Technologies
UBS Group

View all funds holding Karyopharm Therapeutics